Tag: Drug discovery

Nvidia collaborates with Genentech to accelerate AI-driven drug discovery

Are you ready to bring more awareness to your brand? Consider becoming a sponsor for The AI Impact Tour. Learn more about the opportunities here. Nvidia is working with Roche Group’s Genentech to help the company pioneer the use of generative AI in drug discovery. The companies today announced a multi-year strategic collaboration that will […]

Read More

Molecular science VR startup Nanome launches AI copilot MARA

VentureBeat presents: AI Unleashed – An exclusive executive event for enterprise data leaders. Network and learn with industry peers. Learn More San Diego-based Nanome, a startup that allows scientists to understand 3D molecular structures in virtual reality, today announced the launch of a generative AI copilot called MARA. Available through a ChatGPT-like web interface, MARA […]

Read More

Future science at the molecular level

Innovating at the intersection of chemistry, biology, and engineering, Professor Brad Pentelute and the Pentelute Lab at MIT invent new chemistry, platforms, and techniques that might revolutionize therapeutics. Their formula in brief: nature-inspired research that begins at the molecular level, infused with state-of-the-art machine learning and automation, aimed at solving real-world problems. Take, for example, […]

Read More

Molecule reduces inflammation in Alzheimer’s models

Though drug developers have achieved some progress in treating Alzheimer’s disease with medicines that reduce amyloid-beta protein, other problems of the disease, including inflammation, continue unchecked. In a new study, scientists at The Picower Institute for Learning and Memory at MIT describe a candidate drug that in human cell cultures and Alzheimer’s mouse models reduced […]

Read More